AzTrials
AzTrials

Premature InfantVPINCT03093337

Psychomotor Therapy for Very Premature Infants

A study testing Early post hospital discharge psychomotor therapy in people with Premature Infant, run by University Hospital, Toulouse at 10 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Our current reflexion is that sensory dys-stimulations, including vestibule-proprioceptive disorders and unbalanced between brain and brainstem maturation of the neonatal period involve an early deviant development for immature infants that will be cascaded through the brain scaffolding and later development. Read more about this study

Who is it for?
Ages 24 to 30 weeks
Conditions the study is for
Premature Infant
What is being tested?
Early post hospital discharge psychomotor therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
162 participants
Where
10 sitesFrance
Study dates
1 Dec 2007to 8 Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 to 30 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Infants with a gestational age between 24 and 30 weeks.

Who cannot join

  • Infants with congenital disease,
  • Infants with brain bleeding grade III-IV,
  • Infants with periventricular leucomalacia,
  • Infants whose mothers had a documented history of physical or mental illness, or drug abuse
  • Infants from non-French -speaking families.

Trial locations and contacts

10 sites in 1 country.

10 sites in 1 country

France10 sites
  • CH Albi

    Albi, Midi-Pyrénées, 81013

  • CH Auch

    Auch, Midi-Pyrénées, 32008

  • CH Cahors

    Cahors, Midi-Pyrénées, 46005

  • CH Castres

    Castres, Midi-Pyrénées, 81108

  • CHIVA centre hospitalier du val d'Ariège

    Foix, Midi-Pyrénées, 09017

  • CH Montauban

    Montauban, Midi-Pyrénées, 82013

  • CH Tarbes

    Tarbes, Midi-Pyrénées, 65013

  • Hôpital des enfants

    Toulouse, Midi-Pyrénées, 30159

  • Clinique Sarrus Teinturiers

    Toulouse, Midi-Pyrénées, 31076

  • Clinique Ambroise Paré

    Toulouse, Midi-Pyrénées, 31082

Other trials in France

About this study

Official title: Early Post Hospital Discharge Psychomotor Therapy Intervention Program: Effect on the Development in Very Preterm Infants at 2-years Corrected Age

Our current reflexion is that sensory dys-stimulations, including vestibule-proprioceptive disorders and unbalanced between brain and brainstem maturation of the neonatal period involve an early deviant development for immature infants that will be cascaded through the brain scaffolding and later development. The primary purpose is to determine whether the Early Psychomotor Therapy Intervention Program improves development and behavior in very preterm infants (VPI) at 24-month corrected age (CA).

Read the detailed description

VPI < 30 week of amenorrhea were randomized, in a simple blind controlled trial. The psychomotor development was evaluated according to the Bayley Scales of Infant Development-III (BSID-III) at 2 years CA. An intermediate point was provided at 9 months CA. Pediatric standardized assessments and psychologist semi-directive interviews were conducted. Parents also completed a self-administering questionnaire relating to the post-traumatic stress. The intervention consisted on 20 therapy sessions between 2 and 9 months CA, in order to support infants' development, and parent-infant interactions and adjustment.

Extended description of the protocol, including more technical information (as compared to the Brief Summary) if desired. Do not include the entire protocol; do not duplicate information recorded in other data elements, such as eligibility criteria or outcome measures.

Being tested
Early post hospital discharge psychomotor therapy
Keywords
Neuromotor sequelae, Cognitive disorders, Cerebral development, Psychomotoricity, Postural management, Motor coordination, Parenthood
Medical subject headings
Premature Birth, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early post hospital discharge psychomotor therapyOther

    The intervention consisted on 20 psychomotor therapy sessions between 2 and 9 months, in order to support infants' development, and parent-infant interactions and adjustment. The therapy was based on body and emotional positive feelings and experiences, leading to improve sensory motor and perceptive integration, interactive and exploratory behaviors, physiological and tonic-emotional self-regulation, motor organization and early coordination. The intervention was a partnership with the parents, leading to decode the baby needs and expectations, for the parents to experiment more positive feelings, to become more confident in their own skills and more sensitive, and in synchrony with their baby. Intervention was supported by a detailed assessment scale implemented in the regional network related to the follow-up for vulnerable babies.

Study groups in NCT03093337
Study groupRoleWhat they receive
Psychomotor therapyExperimentalEarly post hospital discharge psychomotor therapy.
Receives: Other: Early post hospital discharge psychomotor therapy
ControlNo interventionNo specific support.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychomotor development assessment.

    Assessed by the Bayley Scale Third Edition BSID-III.

    Measured: Year 2

Secondary outcomes (3)
  1. The acceptability of the protocol by the parents for the intervention group.

    Assessed by a self-questionnaire given by the neonatologist at the end of the treatment.

    Measured: Month 9

  2. The quality of parenting.

    Assessed by a grid (established by the team of child psychiatry neonatology).

    Measured: Month 9; Year 2

  3. The clinical evolution of the child assessed by a standardized neurological examination.

    Assessed during the consultations planned in the network (neonatologists of the CHU), based on a standardized neurological examination.

    Measured: Months 3, 6, 9, 12, 18, 24

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2017
  2. Study start1 Dec 2007
  3. Primary completion1 Dec 2013
  4. Study completion8 Jul 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
162 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03093337
Sponsor's protocol ID
07 227 01
Other IDs
2007-A00997-46
Acronym
VPI
Status last verified
Mar 2026
First submitted
14 Mar 2017
Last updated
6 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Jacobsson B, Hagberg G. Antenatal risk factors for cerebral palsy. Best Pract Res Clin Obstet Gynaecol. 2004 Jun;18(3):425-36. doi: 10.1016/j.bpobgyn.2004.02.011.

    PubMed 15183137
  • Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997 Apr;39(4):214-23. doi: 10.1111/j.1469-8749.1997.tb07414.x.

    PubMed 9183258
  • Weisglas-Kuperus N, Koot HM, Baerts W, Fetter WP, Sauer PJ. Behaviour problems of very low-birthweight children. Dev Med Child Neurol. 1993 May;35(5):406-16.

    PubMed 7684346
  • Alberge C, Ehlinger V, Noack N, Bolzoni C, Colombie B, Breinig S, Dicky O, Delobel M, Arnaud C. Early psychomotor therapy in very preterm infants does not improve Bayley-III scales at 2 years. Acta Paediatr. 2023 Sep;112(9):1916-1925. doi: 10.1111/apa.16848. Epub 2023 Jun 5.

    PubMed 37191836

Questions about this trial

What is this clinical trial studying?

A study testing Early post hospital discharge psychomotor therapy in people with Premature Infant, run by University Hospital, Toulouse at 10 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychomotor development assessment. (time frame: Year 2). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03093337, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in